Trial Profile
Apremilast as Anti-pruritic Treatment in Patients With Prurigo Nodularis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 02 Jul 2020
Price :
$35
*
At a glance
- Drugs Apremilast (Primary)
- Indications Prurigo nodularis
- Focus Therapeutic Use
- 19 Apr 2019 Status changed from recruiting to completed.
- 05 Jun 2017 New trial record